Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples